←Back to Expert Scholars
Translational Medicine / 转化医学BTK Inhibitor Resistance and Translational Biology
Javier Pinilla-Ibarz
MD, PhD
🏢Moffitt Cancer Center🌐USA
Senior Member, Lymphoma Section
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Javier Pinilla-Ibarz leads translational studies of BTK inhibitor activity and resistance in chronic lymphocytic leukemia at Moffitt. His laboratory and clinical work dissect patterns of response and relapse on targeted therapy. He contributes to cooperative group trials in CLL.
Share:
🧪Research Fields 研究领域
CLL
BTK inhibitors
resistance
translational leukemia
clinical trials
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Javier Pinilla-Ibarz 的研究动态
Follow Javier Pinilla-Ibarz's research updates
留下邮箱，当我们发布与 Javier Pinilla-Ibarz（Moffitt Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment